The two adenoma cohorts were analyzed for the presence of hotspot pathogenic variants in the most frequently mutated CRC oncogenes (KRAS, NRAS, BRAF and PIK3CA), but no significant differences were found (Fig. 1). This evidence concerns the gene NRAS and adenoma.